Elisabetta Di Leo

Acquaviva Delle Fonti, 70021, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Integrating Technology into Urticaria Management: Telemedicine, Remote Monitoring and Patient-Centered Care.

Integrating Technology into Urticaria Management: Telemedicine, Remote Monitoring and Patient-Centered Care.

Journal: Biomedicines

Published: February 12, 2026

Effectiveness and Safety of Dupilumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Associated T2 Comorbidities: One-Year Real Life Round.

Effectiveness and Safety of Dupilumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Associated T2 Comorbidities: One-Year Real Life Round.

Journal: Journal of clinical medicine

Published: December 10, 2025

Correction to: SIRM‑SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media.

Correction to: SIRM‑SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media.

Journal: Clinical and molecular allergy : CMA

Published: August 22, 2024

The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey.

The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey.

Journal: European annals of allergy and clinical immunology

Published: March 17, 2023

Immunologic contact urticaria to milk in an adult patient with severe atopic dermatitis.

Immunologic contact urticaria to milk in an adult patient with severe atopic dermatitis.

Journal: Contact dermatitis

Published: February 20, 2023

Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life.

Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life.

Journal: Clinical and molecular allergy : CMA

Published: February 24, 2022

Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder.

Quality of life in patients with allergic and immunologic skin diseases: in the eye of the beholder.

Journal: Clinical and molecular allergy : CMA

Published: October 04, 2021

Angioedema associated with dipeptidyl peptidase-IV inhibitors.

Angioedema associated with dipeptidyl peptidase-IV inhibitors.

Journal: Clinical and molecular allergy : CMA

Published: April 25, 2021

Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response.

Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: February 08, 2021

Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis.

Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis.

Journal: Clinical and molecular allergy : CMA

Published: October 06, 2020

Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study.

Use of Dupilumab in 543 Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Retrospective Study.

Journal: Journal of investigational allergology & clinical immunology

Published: August 29, 2020

Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro management.

Safety of measles, mumps, and rubella vaccine in egg allergy: in vivo and in vitro management.

Journal: Clinical and molecular allergy : CMA

Published: August 21, 2020

Showing 1-12 of 49

Last Updated: 09/26/2026